Skip to main content
Erschienen in: International Journal of Clinical Oncology 4/2023

06.02.2023 | Original Article

A meta-analysis and systematic review of the comparison of laparoscopic ablation to percutaneous ablation for hepatic malignancies

verfasst von: Joslin R. Musick, Jeremy T. Gaskins, Robert C. G. Martin

Erschienen in: International Journal of Clinical Oncology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

The optimal access for thermal ablation of the liver has not been evaluated in the literature for the laparoscopic versus percutaneous techniques. The aim of this manuscript was to determine the optimal ablation technique and patient selection for hepatic malignancies by comparing the efficacy and recurrence-free survival of laparoscopic and percutaneous thermal ablation.

Methods

A detailed literature search was made in PubMed, Web of Science, Google scholar, and EMBASE for related research publications. The data were extracted and assessed by two reviewers independently. Analysis of pooled data was performed, and Odds Ratio (OR) or Hazard Ratio (HR) with corresponding confidence intervals (CIs) was calculated and summarized respectively.

Results

A total of 10 articles were included with 1916 ablation patients. Laparoscopic ablation success (Median 100%) was found to be higher than percutaneous ablation success (median 89.4%) (p = ns). There was a higher percentage of both local and non-local hepatic recurrence in the patients treated with percutaneous ablation versus laparoscopic ablation. Meta-analysis indicated no difference in the adjusted hazard rate of recurrence by procedure type (p = 0.94). Laparoscopic ablation had a higher percentage of complications compared to percutaneous ablation (median lap 14.5% vs. perc 3.3%).

Conclusions

While laparoscopic and percutaneous ablation are both effective interventions for hepatic malignancies, laparoscopic ablation was found to have improved ablation success and less local and non-local hepatic recurrence compared to percutaneous ablation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Global Cancer Facts & Figures 4th Edition (Ebook) (2018). Atlanta, USA: American Cancer Society Global Cancer Facts & Figures 4th Edition (Ebook) (2018). Atlanta, USA: American Cancer Society
2.
Zurück zum Zitat Galle PR (2016) Extended abstract: management of liver cancer. Dig Dis 34(4):438–9 (PubMed PMID: 27170399. Epub 2016/05/14)CrossRefPubMed Galle PR (2016) Extended abstract: management of liver cancer. Dig Dis 34(4):438–9 (PubMed PMID: 27170399. Epub 2016/05/14)CrossRefPubMed
4.
Zurück zum Zitat North DA, Groeschl RT, Sindram D et al (2014) Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. Am J Surg 208(2):284–94 (PubMed PMID: 24970652. Epub 2014/06/28)CrossRefPubMed North DA, Groeschl RT, Sindram D et al (2014) Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. Am J Surg 208(2):284–94 (PubMed PMID: 24970652. Epub 2014/06/28)CrossRefPubMed
5.
Zurück zum Zitat Frezza EE (2004) Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses. Dig Dis Sci 49(5):866–71 (PubMed PMID: 15259511. Epub 2004/07/21)CrossRefPubMed Frezza EE (2004) Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses. Dig Dis Sci 49(5):866–71 (PubMed PMID: 15259511. Epub 2004/07/21)CrossRefPubMed
6.
Zurück zum Zitat Hinshaw JL, Lubner MG, Ziemlewicz TJ et al (2014) Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation–what should you use and why? Radiographics 34(5):1344–62 (PubMed PMID: 25208284. PMCID: PMC4319523. Epub 2014/09/11)CrossRefPubMed Hinshaw JL, Lubner MG, Ziemlewicz TJ et al (2014) Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation–what should you use and why? Radiographics 34(5):1344–62 (PubMed PMID: 25208284. PMCID: PMC4319523. Epub 2014/09/11)CrossRefPubMed
7.
Zurück zum Zitat Wright AS, Sampson LA, Warner TF et al (2005) Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236(1):132–9 (PubMed PMID: 15987969. Epub 2005/07/01)CrossRefPubMed Wright AS, Sampson LA, Warner TF et al (2005) Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236(1):132–9 (PubMed PMID: 15987969. Epub 2005/07/01)CrossRefPubMed
8.
Zurück zum Zitat Andreano A, Brace CL (2013) A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver. Cardiovasc Intervent Radiol 36(2):505–11 (PubMed PMID: 22572764. Pubmed Central PMCID: PMC3437379. Epub 2012/05/11)CrossRefPubMed Andreano A, Brace CL (2013) A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver. Cardiovasc Intervent Radiol 36(2):505–11 (PubMed PMID: 22572764. Pubmed Central PMCID: PMC3437379. Epub 2012/05/11)CrossRefPubMed
9.
Zurück zum Zitat Eun HS, Lee BS, Kwon IS et al (2017) Advantages of laparoscopic radiofrequency ablation over percutaneous radiofrequency ablation in hepatocellular carcinoma. Dig Dis Sci 62(9):2586–600 (PubMed PMID: 28744835. Epub 2017/07/27)CrossRefPubMed Eun HS, Lee BS, Kwon IS et al (2017) Advantages of laparoscopic radiofrequency ablation over percutaneous radiofrequency ablation in hepatocellular carcinoma. Dig Dis Sci 62(9):2586–600 (PubMed PMID: 28744835. Epub 2017/07/27)CrossRefPubMed
10.
Zurück zum Zitat De Cobelli F, Marra P, Ratti F et al (2017) Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : new advances in interventional oncology: state of the art. Med Oncol 34(4):49 (PubMed PMID: 28220346. Epub 2017/02/22)CrossRefPubMed De Cobelli F, Marra P, Ratti F et al (2017) Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : new advances in interventional oncology: state of the art. Med Oncol 34(4):49 (PubMed PMID: 28220346. Epub 2017/02/22)CrossRefPubMed
11.
Zurück zum Zitat Zhang W, Jiang L, Yan L et al (2016) Radiofrequency ablation for HCC patients with multifocal tumours meeting the Milan criteria: a single-centre experience. Dig Liver Dis 48(12):1485–91 (PubMed PMID: 27495779. Epub 2016/08/09)CrossRefPubMed Zhang W, Jiang L, Yan L et al (2016) Radiofrequency ablation for HCC patients with multifocal tumours meeting the Milan criteria: a single-centre experience. Dig Liver Dis 48(12):1485–91 (PubMed PMID: 27495779. Epub 2016/08/09)CrossRefPubMed
12.
Zurück zum Zitat Ding J, Jing X, Wang Y et al (2016) Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol 71(12):1270–6 (PubMed PMID: 27510559. Epub 2016/08/12)CrossRefPubMed Ding J, Jing X, Wang Y et al (2016) Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol 71(12):1270–6 (PubMed PMID: 27510559. Epub 2016/08/12)CrossRefPubMed
13.
Zurück zum Zitat Groeschl RT, Pilgrim CH, Hanna EM et al (2014) Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg 259(6):1195–200 (PubMed PMID: 24096760. Epub 2013/10/08)CrossRefPubMed Groeschl RT, Pilgrim CH, Hanna EM et al (2014) Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg 259(6):1195–200 (PubMed PMID: 24096760. Epub 2013/10/08)CrossRefPubMed
14.
Zurück zum Zitat Wong J, Lee KF, Yu SC et al (2013) Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results. HPB (Oxford) 15(8):595–601 (PubMed PMID: 23458320. Pubmed Central PMCID: PMC3731580. Epub 2013/03/06)CrossRefPubMed Wong J, Lee KF, Yu SC et al (2013) Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results. HPB (Oxford) 15(8):595–601 (PubMed PMID: 23458320. Pubmed Central PMCID: PMC3731580. Epub 2013/03/06)CrossRefPubMed
15.
Zurück zum Zitat Hirooka M, Kisaka Y, Uehara T et al (2009) Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites. Dig Endosc 21(2):82–6 (PubMed PMID: 19691779. Epub 2009/08/21)CrossRefPubMed Hirooka M, Kisaka Y, Uehara T et al (2009) Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites. Dig Endosc 21(2):82–6 (PubMed PMID: 19691779. Epub 2009/08/21)CrossRefPubMed
16.
Zurück zum Zitat Yokoyama T, Egami K, Miyamoto M et al (2003) Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg 10(6):425–7 (PubMed PMID: 14714162. Epub 2004/01/10)CrossRefPubMed Yokoyama T, Egami K, Miyamoto M et al (2003) Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg 10(6):425–7 (PubMed PMID: 14714162. Epub 2004/01/10)CrossRefPubMed
17.
Zurück zum Zitat Wood TF, Rose DM, Chung M et al (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7(8):593–600 (PubMed PMID: 11005558. Epub 2000/09/27)CrossRefPubMed Wood TF, Rose DM, Chung M et al (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7(8):593–600 (PubMed PMID: 11005558. Epub 2000/09/27)CrossRefPubMed
18.
Zurück zum Zitat Della Corte A, Ratti F, Monfardini L et al (2020) Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma. Int J Hyperthermia 37(1):542–8 (PubMed PMID: 32469252. Epub 2020/05/30)CrossRefPubMed Della Corte A, Ratti F, Monfardini L et al (2020) Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma. Int J Hyperthermia 37(1):542–8 (PubMed PMID: 32469252. Epub 2020/05/30)CrossRefPubMed
Metadaten
Titel
A meta-analysis and systematic review of the comparison of laparoscopic ablation to percutaneous ablation for hepatic malignancies
verfasst von
Joslin R. Musick
Jeremy T. Gaskins
Robert C. G. Martin
Publikationsdatum
06.02.2023
Verlag
Springer Nature Singapore
Erschienen in
International Journal of Clinical Oncology / Ausgabe 4/2023
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-023-02304-2

Weitere Artikel der Ausgabe 4/2023

International Journal of Clinical Oncology 4/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.